Protalix Biotherapeutics Inc (PLX)
Revenue
$19.90M
Quarterly · Period ending: · USD
PLX Revenue
Latest reported$19.90Mperiod ending
Latest reported$19.90Mperiod ending
PLX Quarterly Revenue ($0.00 → $19.90M)
Quarterly revenue
High-resolution chart · PNG
PLX revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Revenue (USD) |
|---|---|
| 19,896,000 | |
| 33,750,000 | |
| 9,122,000 | |
| 17,851,000 | |
| 15,658,000 | |
| 10,113,000 | |
| 18,218,000 | |
| 17,959,000 | |
| 13,474,000 | |
| 3,748,000 | |
| 10,486,000 | |
| 10,345,000 | |
| 35,075,000 | |
| 9,588,000 | |
| 8,617,000 | |
| 14,183,000 | |
| 8,753,000 | |
| 16,085,000 | |
| 8,549,000 | |
| 12,054,000 | |
| 6,427,000 | |
| 11,320,000 | |
| 19,495,000 | |
| 10,790,000 | |
| 10,967,000 | |
| 21,646,000 | |
| 17,759,000 | |
| 14,248,000 | |
| 12,247,000 | |
| 10,439,000 | |
| 27,018,000 | |
| 12,335,000 | |
| 4,838,000 | |
| 4,553,000 | |
| 2,469,000 | |
| 7,526,000 | |
| 6,358,000 | |
| 2,889,000 | |
| 2,081,000 | |
| 4,670,000 | |
| 1,769,000 | |
| 679,000 | |
| -11,195,000 | |
| 5,846,000 | |
| 1,336,000 | |
| 1,692,000 | |
| 1,384,000 | |
| 3,707,000 | |
| 2,686,000 | |
| 7,383,000 | |
| 1,122,000 | |
| 3,359,000 | |
| 3,064,000 | |
| 3,968,000 | |
| 48,000 | |
| 5,390,000 | |
| 25,258,000 | |
| 3,728,000 | |
| 2,362,000 | |
| 1,132,000 | |
| 764,000 | |
| 6,000,000 | |
| 1,176,000 | |
| 3,184,000 | |
| 1,141,000 | |
| 1,141,000 | |
| 388,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 150,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |